FONAR Corporation (FONR)
NASDAQ: FONR · Real-Time Price · USD
15.14
+0.03 (0.20%)
Dec 20, 2024, 4:00 PM EST - Market closed

Company Description

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.

It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.

It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies.

In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities.

FONAR Corporation was founded in 1978 and is based in Melville, New York.

FONAR Corporation
FONAR logo
Country United States
Founded 1978
IPO Date Jan 1, 1987
Industry Diagnostics & Research
Sector Healthcare
Employees 520
CEO Timothy Damadian

Contact Details

Address:
110 Marcus Drive
Melville, New York 11747
United States
Phone 631-694-2929
Website fonar.com

Stock Details

Ticker Symbol FONR
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000355019
CUSIP Number 344437405
ISIN Number US3444374058
Employer ID 11-2464137
SIC Code 3845

Key Executives

Name Position
Timothy R. Damadian M.D. Chairman, President, Chief Executive Officer and Treasurer
Luciano B. Bonanni Chief Operating Officer, Executive Vice President and Acting Principal Financial Officer
Claudette J. V. Chan Secretary and Director
Daniel Culver Director of Communications

Latest SEC Filings

Date Type Title
Dec 13, 2024 8-K Current Report
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 SCHEDULE 13G Filing
Nov 12, 2024 8-K Current Report
Nov 12, 2024 10-Q Quarterly Report
Sep 30, 2024 8-K Current Report
Sep 27, 2024 10-K Annual Report
May 21, 2024 8-K Current Report
May 16, 2024 8-K Current Report
May 15, 2024 10-Q Quarterly Report